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ABSTRACT: Cyanobactin heterocyclases share the same
catalytic domain (YcaO) as heterocyclases/cyclodehydratases
from other ribosomal peptide (RiPPs) biosynthetic pathways.
These enzymes process multiple residues (Cys/Thr/Ser) within
the same substrate. The processing of cysteine residues proceeds
with a known order. We show the order of reaction for threonines
is diﬀerent and depends in part on a leader peptide within the
substrate. In contrast to other YcaO domains, which have been
reported to exclusively break down ATP into ADP and inorganic
phosphate, cyanobactin heterocyclases have been observed to
produce AMP and inorganic pyrophosphate during catalysis. We
dissect the nucleotide proﬁles associated with heterocyclization
and propose a unifying mechanism, where the γ-phosphate of
ATP is transferred in a kinase mechanism to the substrate to yield a phosphorylated intermediate common to all YcaO domains.
In cyanobactin heterocyclases, this phosphorylated intermediate, in a proportion of turnovers, reacts with ADP to yield AMP
and pyrophosphate.
Ribosomal peptide natural products, known as RiPPs, arean intriguing class of genetically encoded post-transla-
tionally modiﬁed molecules produced by bacteria, plants, and
fungi.1 The substrate peptide has a core of amino acids that
becomes the ﬁnal product and is ﬂanked by recognition
sequences. In bacteria, the substrate peptide often contains
multiple cores, each giving rise to diﬀerent products. In
contrast to the diversity of the amino acid sequence, the
recognition sequences and the processing enzymes are often
well conserved between bacteria. The collection of processing
enzymes varies but almost always includes a protease and, for
macrocyclic RiPPs, a macrocyclase. The exemplar system is
that of patellamides, from the bacterium Prochloron didemni, a
symbiont of Lissoclinum patella, where the entire biosynthetic
gene cluster has been sequenced.2−5 The patellamide cluster
produces two eight-residue macrocycles, patellamide A and C,
from a single substrate peptide, PatE. Each product contains
two thiazoles and two oxazolines, as well as two D-amino acids.
The structures of the enzymes that carry out the proteolysis
(PatA),6 formation of the azolines PatD homologues TruD
and LynD,7,8 oxidation of the thiazolines (PatG oxidase
domain),9 nonfunctional prenylating enzyme (PatF),10 and
macrocyclization (PatG macrocyclization domain)11 have been
reported as well as the structure of a domain of unknown
function found in both PatA and PatG.12
The ﬁve-membered heterocyclic rings (azol(in)es) are found
in a wide range of RiPPs that include the linear azol(in)e-
containing peptides (known as LAPS), cyanobactins, thiopep-
tides, and bottromycins.1 The ring results from the formation
of a bond between the amino acid side chain oxygen or sulfur
atom (from cysteine, serine, or threonine) and the preceding
amide bond.13 ATP and Mg2+ are required for heterocycliza-
tion enzyme activity, and all heterocyclase enzymes share the
same catalytic unit, the YcaO domain (named after the E. coli
homologue).14 The YcaO domain works in conjunction with a
substrate recognition unit, known as the RiPP recognition
element (RRE),15 which can either be fused to the YcaO
domain or occur as a separate protein. The combined system
works on multiple residues within the same substrate in a
distributive manner. Some enzymes catalyze the formation of
both (methyl)oxazolines and thiazolines; others appear to yield
only thiazolines. It has been shown for the thiazoline speciﬁc
enzyme TruD8 that installation of thiazolines follows a deﬁned
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order, with the cysteine closest to the C-terminus of the core
being processed ﬁrst in all substrate molecules, before the
enzyme then moves to the next most C-terminal cysteine
residue. The order is retained when multiple cassettes are
present on the same substrate, with the most C-terminal
cysteine on all cassettes being processed ﬁrst.16 BalhCD,17 a
heterocyclase involved in the biosynthesis of linear, azol(in)e-
containing microcins, also showed in general a C-to-N reaction
order. The study on the patellamide system did not address
whether the heterocyclization of serine/threonine residues is
also ordered, nor whether the leader peptide alone determines
the order. This is signiﬁcant because the leader peptide is
known to play a crucial role in both recognition (binds to the
RRE) and in regulating enzyme activity (binding orders the
active site).7 The fusion of the leader sequence to LynD
created an enzyme that processed peptides without the need
for the leader sequence,7 allowing for the investigation of the
role of the leader in the order of heterocyclization.
The ATP chemistry associated with the heterocyclase
enzymes has been reported as yielding ADP + Pi or AMP +
Pi + PPi.
7,8,14,18 The most convincing mechanism has ATP
phosphorylate, the hemiorthoamide that results from the attack
of side chain of the Cys/Ser/Thr residue on the carbonyl of
the preceding amide bonda kinase mechanism (Scheme S1).
However, a kinase mechanism is inconsistent with the
production of AMP + PPi (Scheme S2), rather these products
would suggest adenylation and diphosphokinase type mecha-
nisms. The nucleotide-bound structures of Escherichia coli
YcaO protein and the cyanobactin heterocyclase LynD both
show an arrangement of ATP that is consistent only with a
kinase mechanism, all but eliminating the other mechanisms.
Yet, the observation by diﬀerent laboratories of the production
of AMP and PPi by diﬀerent YcaO enzymes argues it is not a
simple experimental error. Moreover, 18O has been shown to
transfer from carbonyl of the substrate peptide to PPi during
turnover.7 An enzyme operating via two diﬀerent mechanisms
for the same substrate would seem highly unlikely; rather, the
observations could point to something important that has been
overlooked.
Here we report the order of oxazoline formation with an
enzyme that processes both cysteine and serine/threonine
residue. We have also investigated the role of the leader
peptide in controlling the order of reaction. We have
conﬁrmed the production of AMP, ADP, PPi, and Pi using
diﬀerent enzyme variants during catalysis. ATP analogues were
used to eliminate mechanistic hypotheses. We propose that an
enzyme-catalyzed event occurs during the breakdown of
phosphorylated hemiorthoamide that gives rise to AMP and
PPi production. This event is not stoichiometric, and the extent
of its occurrence appears to vary depending on the enzyme
employed. We believe this proposal resolves the apparent
contradictory results extant in the literature.
■ MATERIALS AND METHODS
General Methods. Materials were purchased from Sigma
unless speciﬁed. Peptides were purchased from Biosynthesis or
expressed and puriﬁed with a his-tag.
Protein Production. The construction of the expression
plasmid for MicD Q219GA (pJExpress411-MicD Q219GA)
was carried out in the following manner (Scheme S3). (Step 1)
The plasmid pJExpress411-LynD fusion7 was subjected to site-
directed mutagenesis,3 using the primer pair 5′- GGC-
GCCAAGCTTATGCAATCTACCCCGTTGCTGCAAATT-
3′ and 5′-TGCATAAGCTTGGCGCCGGCGCCTGCA-
CCCGCACC-3′ and the KOD hot start DNA polymerase
kit (Merck). The mixture was subjected to 12 cycles of
denaturation (94 °C for 1 min), annealing (55 °C for 1 min),
and extension (68 °C for 1 min and 55 s), followed by 3 cycles
of 1 min at 95 °C, 1 min at 47 °C, and 1 min and 55 s at 68 °C.
The gene encoding LynD was removed with endonucleases
HindIII and XhoI. (Step 2) The gene encoding MicD
(heterocyclase from Microcystis aeruginosa) was ampliﬁed
from pJExpress-411-MicD (DNA 2.0) using the KOD hot
start DNA polymerase kit (Merck) following the manufac-
turer’s instruction, with the primer pair 5′-CTTCTTAAGC-
TTATGCAGTCGACCCCGCTGCTG-3′ and 5′-C-
TTCTTCTCGAGTTAGAACGGGATGTTGGTCTG-3′.
The ampliﬁed DNA fragment was subjected to endonucleases
HindIII and XhoI and ligated with the vector prepared in step 1
using the DNA ligation kit 2.1 (TAKARA). Plasmids were
recovered from Escherichia coli DH5α (DE3) cells using a
Qiagen miniprep kit and subjected to digestion by NcoI and
HindIII. (Step 3) The sequence QLSSQLAELSEEALGDA-
(GA)9KL was produced with pBMS-PatE2K as a template and
the primer pair 5′-CTTCATATGAGCCATCATCAC-3′ and
5′-CTTCTTAAGCTTGGCGCCTGCGCCAGCACC-
GGCACCGGCGCCGGCGCCTGCACCCGC-3′ using the
KOD hot start DNA polymerase kit (Merck) following the
manufacturer’s instructions. The PCR product was subjected
to the endonucleases NcoI and HindIII and ligated with the
vector prepared in step 2 using the DNA ligation kit 2.1
(TAKARA).
Heterocyclases and their fusion variants were expressed and
puriﬁed following an established protocol.7 The “full length”
substrate peptides PatE2K and PatE3KK (Scheme S4) were
expressed with a C-terminal, noncleavable his-tag and puriﬁed
as previously described.19
Alkylation of Peptides. PatE2K/PatE3KK (100 μM) and
ITACITFCAYD/ITACITFCAYDG (100 μM) were reacted
with MicD (5 μM) and MicD Q219GA (5 μM), respectively,
for 3 h at 25 °C in 20 mM Tris pH 8.0 supplemented with 150
mM NaCl, 10 MgCl2, 10 mM ATP, and 1 mM DTT. The
reactions were terminated by the addition of EDTA to the ﬁnal
concentration of 50 mM. Five mM alkylating agent
iodoacetamide (IAA) was added to an aliquot of each, which
was kept at room temperature away from light for 30 min.
Excess IAA was then quenched by the addition of 10 mM
DTT. Samples were subjected to MALDI-MS for analysis of
heterocyclization and alkylation. Doubly heterocylized Pa-
tE3KK and ITACITFCAYDG were further analyzed by ESI-
MS/MS; PatE3KK was treated with trypsin before analysis.
Radioactive Assay. ATP [α-32P] was purchased from
PerkinElmer. PEI cellulose plates (Macherey-Nagel) were
prerinsed with water and used after drying. All experiments
were performed in duplicate. Assays were performed in 100
mM Tris pH 8.0, 50 mM NaCl, 5 mM DTT (MicD) or 1 mM
TCEP (LynD and LynD fusion), and 10 mM MgCl2 at 25 °C.
For MicD, assays were performed with or without 150 μM
E2K and 20 μM enzyme; for LynD and LynD fusion, assays
were performed with 100 μM E2K and 5 μM enzyme. All
reactions and controls contained 250 nM cold ATP and 50 μCi
ATP [α-32P]. At desired time points, 6 μL aliquots from the
reaction were removed and mixed with 1 μL of 500 mM
EDTA (71 mM after quenching), and 1 μL of the quenched
time point mixtures was directly spotted on a TLC plate. For
MicD, the reaction was quenched at 15 s, 30 s, 1, 2, 5, 10, and
Biochemistry Article
DOI: 10.1021/acs.biochem.9b00084
Biochemistry 2019, 58, 2125−2132
2126
30 min. For LynD and LynD fusion, the reaction was
quenched after 1 h. TLC plates ran in 0.9 M guanidinium
HCl and were dried prior to exposure using a BA phosphor
screen (GE Healthcare). The phosphor screen was imaged
using a Typhoon FLA7000 (GE Healthcare), spots quantiﬁed
using ImageJ, followed by data analysis using Prism. Reactions
to be used as positive controls were performed by adding 5 μM
hexokinase + 0.5 mM glucose (for ADP production) or 5 μM
Aapyrase (for AMP production) to the same reaction mixture
used for the reactions with LynD or MicD. Negative controls
containing just ATP and each enzyme + ATP in the absence of
E2K were performed. Reactions were carried out simulta-
neously with positive and negative controls and ran on the
same day and same TLC plates using identical conditions.
Spots on the TLC plate were used to quantify nucleotides
using the relationship 250 nM = [ATP] + [ADP] + [AMP].
EnzChek (Pyro)phophosphate Assay. The EnzChek
Pyrophosphate Assay kit was purchased from Thermo Fisher.
Each reaction contains the following components: 100 mM
Tris pH 8.0, 50 mM NaCl, 10 mM MgCl2, 5 mM DTT, 200
μM 2-amino-6-mercapto-7-methylpurine riboside (MESG), 1
U purine nucleoside phosphorylase (PNP), and when
indicated 10 μM Mycobacterium tuberculosis pyrophosphatase
(MtPPase, a kind gift from Dr. Luiz Pedro de Carvalho of the
Francis Crick Institute). Concentrations of enzymes, peptides,
and nucleotides were varied in individual reactions. MtPPase
was puriﬁed following an established protocol.20 Assays were
carried out in 100 μL or 200 μL reaction volumes in 96-well
plates, and the absorbance at 360 nm was monitored by a
SpectraMax plate reader (Molecular Devices).
High-Performance Liquid Chromatography. Hetero-
cyclization of ITACITFCAYD by MicD fusion in the presence
of ATP, ADP, or AMP-CPP was carried out in HPLC assay
buﬀer (100 mM Tris pH 8.0, 50 mM NaCl, 10 mM MgCl2, 5
mM TCEP). The reactant concentrations, reaction time, and
temperature varied and are individually speciﬁed. Reactions
were terminated by the addition of two volumes of urea
quench buﬀer (8 M urea, 20 mM Tris pH 8.0, 500 mM NaCl,
10 μM L-tryptophan (L-tryptophan added as an internal
standard for MS analyses)) and then incubated with 120 μM
Ni-NTA agarose resin (ABT) in a Corning centrifuge tube
ﬁlter for 30 min at room temperature. After centrifugation at
4000g for 10 min, the ﬂow through was collected and applied
to an EC 250/4.6 NUCLEODUR 300-5 C18 column
(Thames-Restek) connected to a G6130B Single Quad LC-
MS instrument (Agilent Technologies). The column was pre-
equilibrated in solvent A (5 mM Ammonium Bicarbonate pH
7.0), and after sample application, a stepwise isocratic program
was run at a ﬂow rate of 1 mL/min for a total of 11 min to
separate the reactants and products: 80% solvent A, 20%
solvent B (95% acetonitrile) for 3 min, followed by 50% A,
50% B for 3 min, and ﬁnally 100% B for 5 min. Separation of
linear and heterocyclized peptides was not achieved by this
method, and therefore, diﬀerent selected ion monitoring
(SIM) channels were set up to give separate ion chromato-
grams of these peptides. The following three SIM channels
(negative mode) were set up: (1) AMP or AMP-CP and
ITACITFCAYD, (2) ATP or AMP-CPP and ITACITFCAYD-
1het, (3) ADP and L-tryptophan (internal standard). Ion
intensity peaks were integrated using the Agilent ChemStation
software and corrected against the area of the L-tryptophan
mass peak. Standard curves for the quantitation of AMP, ADP,
ATP, AMP-CP, AMP-CPP, and ITACITFCAYD were
obtained by diluting each compound to various concentrations
in HPLC assay buﬀer and adding two volumes of urea quench
buﬀer, before applying the samples to the HPLC-MS system.
For determining the degree of heterocyclization, reactions
were set up between 25, 50, and 100 μM ITACITFCAYD and
1 mM AMP-CPP, catalyzed by MicD Q219GA (5 μM). The
reactions were incubated at room temperature for 16 h and
quenched with 2× volumes of urea quench buﬀer. The enzyme
was removed using a ﬁltration device, and the ﬂow through was
subjected to HPLC-MS as described above, except that a
diﬀerent solvent gradient was run: 20%−60% B from 0−10
min, 95% B from 10−15 min. Masses corresponding to the
unmodiﬁed, singly and doubly heterocyclized peptides were
entered into mass selective detectors (MSDs) 2, 3, and 4,
respectively.
Duplicated time course experiments were carried out with
MicD Q219GA (20 μM) with ITACITFCAYD (50 μM) and
ATP or AMP-CPP (10 μM). The reaction containing ATP was
performed at 25 °C, with samples withdrawn from the reaction
mix at 15, 30, 60, 120, 300, and 600 s after the start of the
reaction, and quenched by being mixed with two volumes of
urea quench buﬀer. The AMP-CPP reaction was carried out in
separate aliquots and incubated at 30 °C; reactions were
quenched after 15, 30, 60, 120, and 240 min after initiation.
Areas of ion intensity peaks (peptides, nucleotides, and L-
tryptophan) were integrated and plotted, as a ratio of peptide
or nucleotide over tryptophan, against time. Standard curves
for ATP, ADP, AMP, and AMP-CPP were employed to
calculate the concentrations of these nucleotides. Due to
diﬃculties in obtaining a pure, singly heterocyclized peptide,
the concentration of this compound was obtained from
normalized data. The AMP-CPP reaction was assumed to
have reached completion by the end of the incubation period,
and the ion intensity readings of the 1het species at time 0 and
240 min (adjusted against tryptophan), respectively, were used
as a minimum (0%) and maximum (100% or 10 μM), and a
linear relationship between area ratio and peptide concen-
tration existed within this range. The same slope (area ratio/
concentration) was then used to normalize data from the ATP
reaction. AMP-CP concentrations were estimated based on
normalized data, with the peak ratio value at time 0 set as 0
and the peak ratio value at 240 min as 100% (10 μM),
assuming linearity within this range.
Nuclear Magnetic Resonance Spectroscopy. Two sets
of NMR experiments were performed: (set 1) the reaction
between 2 mM uniformly labeled (u)-13C,15N-PatE2K and
MicD, for sequential assignment as well as reaction
monitoring; (set 2) the reaction between 100 μM u-15N
PatE2K-2het and MicD. Both sets of experiments were
performed at 20 °C on a Bruker Ascend 700 MHz
spectrometer equipped with a Prodigy TCI probe. The
instrument was controlled by Topspin (Bruker).
For set 1, u-13C,15N-PatE2K was concentrated to 2 mM and
exchanged to a buﬀer containing 50 mM HEPES pH 7.4
supplemented with 150 mM NaCl, 15 mM ATP, 10 mM
MgCl2, 5 mM DTT, 0.02% NaN3, and 5% D2O.
1H,15N-HSQC
(heteronuclear single-quantum coherence spectroscopy) spec-
tra using a standard Bruker pulse sequence incorporating water
ﬂip-back and PEP water suppression at 2028 × 128 points and
a digital resolution of 12.3 and 31.0 Hz for the 1H and 15N
dimensions, respectively, were recorded after 15 min, 30 min, 1
h, and each hour afterward until 66 h after the start of the
reaction. HNCACB and CBCA(CO)NH spectra were
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recorded using standard Bruker pulse sequences with 1536 ×
50 × 104 points and digital resolutions of 12.8, 59.6, and 257
Hz for the 1H, 15N, and 13C dimensions, respectively, for the
starting material and the product after 66 h. All spectra were
processed with NMRPipe21 and analyzed with CCPN Analysis
2.22 All backbone amides, Cα and Cβ resonances of PatE2K,
and product (after a 66 h incubation) were assigned, with the
exception of the two N-terminal residues and the His6-tag at
the C-terminus.
For set 2, 100 μM uniformly labeled 15N-PatE2K-2het
(prepared as previously described)19 was reacted with 5 μM
MicD at 20 °C and the reaction was monitored by recording
1H,15N-HSQC spectra every 30 min for a total of 16 h. Four
transients were recorded at 2048 × 110 points with a spectral
resolution of 12.3 and 36.1 Hz for the 1H and 15N dimensions,
respectively. Spectral data were processed with Bruker Topspin
and analyzed with CCPN Analysis 2.22
Mass Spectrometry. Molecular masses were determined
using matrix-assisted laser desorption ionization time-of-ﬂight
mass spectrometry (MALDI-TOF-MS) on a 4800 MALDI
TOF/TOF analyzer (ABSciex).
Tandem mass spectrometry (MSMS) data of peptides were
collected on an AB SCIEX Triple TOF 5600+ system
equipped with an Eksigent nanoLC. Samples were ﬁrst
desalted by entering into a 5 μL/min ﬂow of 98% H2O, 2%
acetonitrile (ACN), and 0.05% triﬂuoroacetic acid (TFA) and
washed through a Thermo Pepmap 20 mm × 0.075 mm
column (trap column) for 5 min. The trap column was then
connected to an analytical column (150 mm × 0.075 mm), and
both were equilibrated in 98% H2O, 2% ACN, and 0.1% formic
acid (FA). Peptides were eluted and separated by switching the
solvent toward 98% ACN, 2% H2O, and 0.1% FA in a linear
gradient over the course of 6 min, with a ﬂow rate of 300 nL/
min, and the eluate was sprayed into the mass spectrometer.
The most intense peaks within the 400−1250 m/z region were
automatically selected in the information dependent acquis-
ition (IDA) mode and directed to collision induced
fragmentation (CID) followed by and ions collected in the
95−1800 m/z range. Alternatively, product ion scan (PIS)
mode was employed where speciﬁed masses were entered into
the program prior to the experiment so that they are selected
for fragmentation. Sample application and data collection were
performed by the University of St Andrews mass spectrometry
facility.
■ RESULTS
Order of Heterocyclization. Previous work using TruD
(heterocyclase from the trunkamides biosynthetic pathway)
and the PatE2K substrate showed that heterocyclization of
cysteine 51 precedes that of cysteine 47 (C8 and C4 of the
core peptide, respectively).8 PatD catalyzes both oxazoline and
thiazoline formation and with PatE2K yields four heterocycles
formed by two cysteine and two threonine residues. However,
PatD has proven to be very diﬃcult to keep stable in solution
in our hands. PatE2K was therefore reacted with MicD
(heterocyclase from the microcyclamides biosynthetic path-
way), which can also modify both cysteines and serines/
threonines. The reaction was analyzed by MALDI-MS without
(Figure 1A) and with (Figure 1A,B) the sample being treated
with iodoacetamide (IAA), an alkylating agent that covalently
modiﬁes cysteine residues resulting in the addition of 57 Da
mass per free cysteine (Figure 1A,B). The experiment shows
no evidence of the IAA modiﬁed peptide with two or more
heterocycles. In contrast, there is clear evidence for a double
adduct of the peptide with no heterocycles and a single adduct
of a peptide with a single heterocycle. Further, MSMS analysis
of the doubly dehydrated species located the heterocycles at
(Figures S1 and S2) positions C4 and C8 of the core peptide.
Thus, we conclude that both cysteines are heterocyclized
before either threonine.
To establish the order of heterocyclization, uniformly 15N-
labeled PatE2K was reacted with MicD, and the 1H,15N-HSQC
spectra were recorded. Interpretation of the HSQCs was based
on a backbone assignment of uniformly 13C,15N-labeled
PatE2K before incubation with MicD (Figure S3, Table S1),
and after 66 h of incubation, which under the conditions
chosen yielded a mixture of peptides containing 1−4
heterocycles (Figure S4B, Figure S5). In the triple-resonance
spectra, up to three diﬀerent states were observed for residues
aﬀected by heterocyclization (Figure S5). Distinct changes in
Cα and Cβ resonances reﬂect heterocyclization of C51, C47,
T45, and T49. As observed previously,8 cysteine Cα and Cβ
resonances undergo dramatic downﬁeld shift changes when the
heterocycles form (strips for I48 and A52 in Figure S5). A
similar eﬀect has now been observed for threonine
heterocyclization (strips for A46 and F50 in Figure S5). In
addition, Cα resonances of I44 and I48 have undergone upﬁeld
chemical shifts in one of their observed states, reﬂecting
heterocyclization of T45 and T49 (Figure S5). These
characteristic changes greatly facilitated interpretation of the
time-dependent changes observed in the HSQCs. C51, judged
by shifts in cross-peaks of I48, T49, F50, A52, Y53, D54, and
G55, reacts ﬁrst, consistent with studies of TruD (Figure
S4A).8 After the ﬁrst modiﬁcation, the situation was more
complex and harder to interpret, with multiple shifts in cross-
peaks (Figure S4B) being observed at similar rates. To simplify
the interpretation of HSQC spectra, uniformly 15N-labeled
PatE2K was reacted with LynD to heterocyclize only the
cysteines. This new peptide was used as a substrate for the
MicD reaction. MicD modiﬁed both T45 and T49 at the same
time (Figure S4C,D), based on shifts in cross-peaks S42, K43,
Figure 1. Alkylation of free cysteines on precursor peptides. PatE2K
(A, B) and ITACITFCAYD (C, D) were reacted with MicD and
MicD fusion, respectively, to a state with a mixed number of
heterocycles. The samples were then reacted with the alkylating agent
iodoacetamide to detect the presence of free cysteines. The numbers
of dehydrations in the product in each m/z species are annotated in
red. Asterisks signify [M + Na]+ species, and the lack of an asterisk
indicates [M + H]+ species; [I] denotes an adduct of +57 Da (mono
alkylation), while [II] denotes two alkylations (+114 Da). The same
analysis, with essentially identical results, was carried out with
PatE3KK (Figure S1), which has the same ITACITFC core sequence
(Scheme S4).
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I44, A46, I48, F50, and A52, thus lacking a deﬁnite order for
the third heterocyclization; however, T45 was depleted at a
higher rate, suggesting a partial order (Figure S4C,D). A
preference for C51 over C47, and for T45 over T49 is also
seen by tandem mass spectrometry (MSMS) analyses (Figure
2A,B; Figures S6 and S7). The triply heterocyclized peptide
showed strong evidence for azolines at T45, C47, and C51 but
not for T49, C47, and C51 (Figure S7). However, ionization
propensity may account for the lack of the T49-containing
species.
We explored the role of the leader peptide in determining
the order of heterocyclization by using the fused enzyme MicD
Q219GA (analogous to the previously reported LynD fusion7)
and ITACITFCAYDG (a leaderless substrate). IAA labeling
shows that cysteines are once again heterocyclized before
threonines (Figure 1C,D, Figures S1 and S8). MS/MS analysis
(Figure 2C, Figure S9) indicates that the reaction order of the
cysteines is retained, as the fragmentation pattern of the singly
dehydrated species corresponds to the presence of a hetero-
cycle at C8 (equivalent to C51 of PatE2K) rather than C4
(equivalent to C47 of PatE2K). In contrast, any order of
threonine heterocyclization appears lost, as T2 (T45 of
PatE2K) and T6 (T49 of PatE2K) heterocycles were both
found in the triply dehydrated species (Figure 2D, Figure S10).
Assay under Single Turnover Conditions. To identify if
ATP consumption was leading to AMP and/or ADP formation
in the ﬁrst heterocyclization event, we performed experiments
in the presence and absence of PatE2K using ATP [α-32P].
Our experiments (Figure 3) were conducted under single
turnover conditions and show that, both in the presence and
absence of PatE2K, ADP is formed as a reaction intermediate,
but with distinct rates of formation and decay. In the absence
of PatE2K, ADP forms quickly (rate of formation (0.044 s−1)),
being completely converted to AMP in 500 s (rate of ADP
decay is 0.005 s−1). In contrast, in the presence of PatE2K,
ADP forms at a slightly slower rate (0.033 s−1) but takes much
longer to be converted into AMP (rate of ADP decay is
0.00013 s−1). AMP is formed quickly in the absence of PatE2K
(rate of formation 0.006 s−1) and slower in the presence of
PatE2K (0.0014 s−1). In the absence of PatE2K, MicD is likely
catalyzing solely ATP hydrolysis to ADP and then to AMP,
while in the presence of PatE2K, ATP consumption is coupled
to heterocyclization, and hence the slower rates observed for
ADP decrease. The reaction with LynD and LynD fusion also
showed ADP formation at similar levels for both enzymes in
agreement with the results obtained for MicD (Figure S11).
Chemical Analogues of ATP. As a positive control,
PatE2K was reacted with ATP for 16 h and up to four
dehydrations were observed by MS (Figure 4A). AMP-CPP
and AMP-NPP, both of which contain a hydrolyzable β−γ and
a nonhydrolyzable α−β phosphate bond, supported multiple
heterocyclization of the test substrate peptide PatE2K by the
heterocyclase MicD (Figure 4B,C). In contrast, AMP-PCP and
AMP-PNP, which have a nonhydrolyzable β−γ and hydro-
lyzable α−β phosphate bond (Figure 4D,E), did not support
catalysis. The analysis of catalysis with AMP-CPP and AMP-
PCP was repeated with heterocyclases LynD and OscD and
gave the same results: AMP-CPP supported catalysis, while
AMP-PCP did not (Figure S12). Mixing AMP-PCP and AMP-
Figure 2. Tandem MS analyses of peptides modiﬁed by MicD or
MicD fusion. Peptides with a variable number of heterocycles were
subjected to MSMS to reveal the location of heterocyclization. (A)
singly and (B) triply dehydrated ITACITFCAYDGEK (produced
from PatE3KK) and (C) singly and (D) triply dehydrated
ITACITFCAYDG. Pentagons signify the modiﬁcation of residues
into heterocycles; left- and right-facing right angles represent b and y
ions, respectively. Full spectra and calculated masses are shown in
Figures S6, S7, S9, and S10. “Full-length” and “leaderless” refer to the
peptide substrate undergoing heterocyclization.
Figure 3. Rate of nucleotide usage under single turnover conditions.
Concentrations of ATP, ADP, and AMP following incubation of ATP
[α-32P] with MicD, in the presence or absence of 100 μM PatE2K.
The concentrations of ATP (red), ADP (blue), and AMP (purple) at
each time point are shown as circles that are empty or ﬁlled to
indicate whether PatE2K (substrate) is absent or present in the
reaction, respectively. Lines are ﬁts to a single (ATP and AMP) or
double (ADP) exponential equation with the general format y(t) =
ΣiAie−kit + y0 where y(t) is the observed signal at time t, i is the
number of transients, Ai is the amplitude of the ith transient, ki is the
observed rate constant for the ith transient, and y0 is the y-axis oﬀset.
Figure 4. Nucleotide usage by the heterocyclase. MALDI-MS spectra
of PatE2K (100 μM) reacted with 2 mM each of (A) ATP, (B) AMP-
CPP, (C) AMP-NPP, (D) AMP-PCP, (E) AMP-PNP, and (F) a mix
of 2 mM AMP-CPP and 2 mM AMP-PCP. The reactions were
catalyzed by MicD (5 μM). SM, starting material. The number of
dehydrations that are present in each m/z species is annotated in red.
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CPP gave the same result as AMP-CPP (Figure 4F). HPLC
analysis of the ATP and AMP-CPP reaction (Figure S15) was
carried out with the fused enzyme MicD Q219GA as a catalyst
with a leaderless peptide, ITACITFCAYD, at various time
points. This reaction is slower than for the native enzyme PatE
substrate combination, which allowed us to monitor
ITACITFCAYD depletion and nucleotide decomposition
more easily. A species with a mass corresponding to singly
heterocyclized peptide appeared as a substrate was consumed.
When ATP is included in the reaction, ADP was observed to
initially accumulate before decomposing to AMP (Figure
S4C), while AMP-CPP gave only AMP-CP (Figure S4D).
We thus concluded that catalysis (only) requires the
breakage of the β−γ phosphate bond, which is the kinase
type mechanism. We do note that the presence of the
nonhydrolyzable α−β phosphate bond does slow the enzyme
very signiﬁcantly when compared to ATP (Figure 4A−C).
Pi and PPi Production. If AMP was produced solely from
ADP hydrolysis, then there should be no PPi production, only
Pi. The amount of Pi released from the heterocyclization
reaction was measured using a coupled assay for both LynD
and MicD enzymes (Figure 2). In both cases, a signiﬁcant
increase in Pi was observed when the enzyme pyrophosphatase
was included, indicating the presence of PPi (Figure 5A,B).
The presence of PPi in these reactions was dependent on the
presence of peptide and so is not the result of some side
reaction of ATP in solution (Figure 5A,B). The production of
PPi during catalysis is consistent with previous
31P NMR
experiments8 and the previous report of 18O incorporation into
PPi.
7 The E. coli YcaO protein was observed to produce AMP
and PPi in the absence of a substrate, but since the substrate is
unknown, the relative rates cannot be estimated for YcaO.18
Interestingly, the result for MicD is diﬀerent to that for LynD.
Ignoring the degradation of PPi in the time of reaction and
assuming all of the increase in Pi from the addition of PPase
comes from PPi produced by the enzyme during turnover, it is
calculated that MicD produces Pi/PPi in the ratio 1:1 whereas
LynD has a ratio of 1:5. Notably, PPi was observed when ADP
was added to a reaction mix containing LynD, AMP-CPP, and
PatE2K (Figure 5C). PPi was not when either nucleotide was
present on its own (Figure 5D,E). The rate of reaction with
AMP-CPP (0.006 s−1) was not, within the error of our
measurements, aﬀected by the presence of ADP (Figure 5C vs
D).
■ DISCUSSION
We have shown that MicD, a heterocyclase capable of
processing both cysteines and threonines, heterocyclizes two
cysteines in the substrate peptide with the same order (C-to N-
terminus) observed previously for TruD and BalhCD.8,17 In a
peptide with two cysteines and two threonines, the cysteine
residues are hetereocyclized before either of the two threonine
residues (Figures 1 and 2). The data suggest that for the
threonines an N-to-C order in the heterocyclization is
preferred but not obligatory, in contrast to the situation with
cysteines where the order seems immutable (Scheme 1). We
explored whether the substrate leader inﬂuences the order of
catalysis by using the fused variant of the MicD enzyme. The
fused enzyme using a leaderless substrate showed cysteines
were processed before threonines (consistent with the relative
nucleophilicity). The data did indicate that the C-to-N order of
the cysteine heterocyclization was conserved, but any
preference for the order of threonines was lost (Figure 2).
The fact that the leader was only one component contributing
to the ordering of heterocyclization echoes the observations
made of the lantibiotic synthetase LctM, where the leader plays
a partial role in determining the reaction order.23 A study of
cyanobactin biosynthetic dehydrogenase enzyme ArtGox also
showed that the order of the reaction (conversion of
thiazolines to thiazoles) was unaﬀected by the presence or
absence of the leader peptide.19
The seemingly contradictory observations around ATP
usage by the heterocyclase class of enzymes has been
discussed.5,7,8,14,18,24 We conﬁrm multiple previous studies
that a cyanobactin heterocyclase produces AMP and PPi
during catalysis. At the same time, a detailed dissection of
the nucleotide usage using nonhydrolyzable analogues
establishes that catalysis requires only the cleavage of the
β−γ phosphate bond (Figure 4). The mechanism is a kinase
type consistent with earlier work,14 but the production of PPi is
unexplained by a simple kinase mechanism. Since the
Figure 5. Production of PPi and Pi under diﬀerent conditions. Level
of phosphate produced following heterocyclase reactions using
diﬀerent nucleotides, in the presence and in the absence of
pyrophosphatase enzyme (PPase). (A) 5 μM MicD reacted with 10
mM ATP and where indicated 20 μM PatE2K. (B) 5 μM LynD
reacted with 1 mM ATP and where indicated, 100 μM PatE2K. (C−
E) 5 μM LynD incubated with 100 μM PatE2K and a mix of 10 mM
AMP-CPP and 10 mM ADP. The reaction was repeated with 10 mM
AMP-CPP or ADP on their own. Reactions were carried out in
duplicates.
Scheme 1. Proposed Order of Heterocyclization by MicDa
aT and C represent heterocyclizable residues, whereas ﬁve-membered
rings represent azolines.
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formation of PPi is not essential for catalysis, we considered it
might arise from a second, oﬀ pathway reaction. An estimate of
the ratio of PPi to Pi production during catalysis showed
diﬀerent values for diﬀerent homologues (MicD, LynD) and
diﬀerent conditions, consistent with the concept of an oﬀ path
reaction. We suspect that, depending on the speciﬁc YcaO type
enzyme and conditions employed, PPi production may vary
from negligible to dominant.
In rationalizing the production of PPi, we note especially the
production of PPi when ADP was added to an enzyme AMP-
CPP reaction (Figure 5C). AMP-CPP breaks down to AMP-
CP and Pi (Figure 5D); AMP-CP cannot undergo further
reaction, and ADP does not support catalysis or produce PPi
(Figure 5E). We propose that the most plausible source of PPi
is from an enzyme-catalyzed reaction between Pi (originating
from AMP-CPP) and ADP to generate AMP and PPi,
essentially a disproportionation or transphosphorylation
reaction (Scheme 2). Single turnover experiments also point
to ADP being an intermediate during catalysis (Figure 3). Our
data do not determine whether the Pi is chemically bound to
the hemiorthoamide or not during the disproportionation
reaction; although given the coupling to enzyme turnover, we
favor the former. We speculate the extensive and unusual metal
coordination of the nucleotide phosphate groups observed in
YcaO domains7,18 is responsible for this unusual chemistry.
This mechanistic proposal reconciles the contradictions in the
literature and divulges a new enzyme-catalyzed transphosphor-
ylation.
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